Jesper Bøje Andersen
Professor
Andersen Group
Ole Maaløes Vej 5
2200 København N.
- Lecture and oral contribution
Cholangiocarcinoma Foundation Congress: Translational genomics: Application of murine models for understanding tumor heterogeneity
Andersen, Jesper Bøje (Invited speaker)
3 Feb 2016 → 6 Feb 2016Activity: Talk or presentation types › Lecture and oral contribution
EASL: Modulation of Demethylation and Antitumor Potential of Zebularine in Liver Cancer
Andersen, Jesper Bøje (Speaker)
2009Activity: Talk or presentation types › Lecture and oral contribution
Emerging Targets in the treatment of Cholangiocarcinoma: Liver cancer seminar
Andersen, Jesper Bøje (Lecturer)
20 Nov 2013Activity: Talk or presentation types › Lecture and oral contribution
European Network Study for Cholangiocarcinoma: 1st International monothematic congress in cholangiocarcinoma: Molecular pathogenesis of intrahepatic cholangiocarcinoma
Andersen, Jesper Bøje (Invited speaker)
4 May 2016 → 6 May 2016Activity: Talk or presentation types › Lecture and oral contribution
Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors
Andersen, Jesper Bøje (Speaker)
2011Activity: Talk or presentation types › Lecture and oral contribution
Georgetown University, Lombardi Comprehensive Cancer Center: Emerging Genomics-based Targets in the treatment of Cholangiocarcinoma: Ruesch symposium on HCC
Andersen, Jesper Bøje (Invited speaker)
2013Activity: Talk or presentation types › Lecture and oral contribution
Hallas-Møller Fellowship
Andersen, Jesper Bøje (Other)
Apr 2015Activity: Talk or presentation types › Lecture and oral contribution
Hepatobiliary cancers: Translational Genomics Directs Therapeutic Options
Andersen, Jesper Bøje (Invited speaker)
Aug 2015Activity: Talk or presentation types › Lecture and oral contribution
Highlight from Hepatology 2015: From Chronic Hepatitis to HCC: Molecular pathogenesis and current therapy in intrahepatic cholangiocarcinoma
Andersen, Jesper Bøje (Invited speaker)
Oct 2015Activity: Talk or presentation types › Lecture and oral contribution
ILCA workshop: Signalling pathways and molecular therapies in liver cancer: Rationale for Targeted Therapies in Intrahepatic Cholangiocarcinoma
Andersen, Jesper Bøje (Speaker)
2012Activity: Talk or presentation types › Lecture and oral contribution
ID: 93714085
Most downloads
-
716
downloads
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles - correction
Research output: Contribution to journal › Comment/debate › Research › peer-review
Published -
574
downloads
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
198
downloads
MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma
Research output: Contribution to journal › Journal article › Research › peer-review
Published